CausalSentinel

Protein Dossier — CEL (Bile salt-activated lipase)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation 0.183 0.0584 0.00167 Wald ratio 1 cis NA
Non-cancer illness code self-reported: chronic obstructive airways disease or copd 0.364 0.122 0.00273 Wald ratio 1 cis NA
Glioma 0.663 0.233 0.00441 Wald ratio 1 cis NA
Sleep duration -0.0206 0.00783 0.00837 Wald ratio 1 cis NA
2hr glucose 0.204 0.0861 0.0176 Wald ratio 1 cis NA
Heel bone mineral density (BMD) T-score automated -0.03 0.0129 0.0205 Wald ratio 1 cis NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine 0.142 0.0615 0.0209 Wald ratio 1 cis NA
Caudate volume 44.9 20.6 0.0295 Wald ratio 1 cis NA
Non-cancer illness code self-reported: emphysema or chronic bronchitis 0.147 0.0754 0.0504 Wald ratio 1 cis NA
Non-cancer illness code self-reported: sleep apnoea 0.273 0.141 0.0531 Wald ratio 1 cis NA
Small vessel disease 0.299 0.161 0.0631 Wald ratio 1 cis NA
Invasive mucinous ovarian cancer 0.323 0.184 0.0792 Wald ratio 1 cis NA
…and 83 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

12 association rows across 11 traits (12 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Bile salt-activated lipase levels 1e-44 rs2075733 2 GCST90427924 no MR -> candidate analysis
ALPI protein levels 1e-25 rs141668780 1 GCST90468285 no MR -> candidate analysis
ABO protein levels 4e-22 rs551202309 1 GCST90468191 no MR -> candidate analysis
PLA2G1B protein levels 2e-17 rs116842520 1 GCST90470246 no MR -> candidate analysis
Type 1 diabetes 4e-17 rs541856133 1 GCST90014023 no MR -> candidate analysis
KIRREL2 protein levels 2e-14 rs526855 1 GCST90469690 no MR -> candidate analysis
Alkaline phosphatase (UKB data field 30610) 3e-14 rs577793545 1 GCST90468060 no MR -> candidate analysis
Serum levels of protein CEL 1e-12 rs509064 1 GCST90090829 no MR -> candidate analysis
CUZD1 protein levels 3e-12 rs75294797 1 GCST90468919 no MR -> candidate analysis
VWF protein levels 7e-12 rs142810361 1 GCST90471065 no MR -> candidate analysis
CD34 protein levels 9e-12 rs139744322 1 GCST90468626 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 239 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
MODY 0.788 established (curated) no MR -> candidate analysis
maturity-onset diabetes of the young 0.608 established (curated) no MR -> candidate analysis
hereditary disease 0.318 established (curated) no MR -> candidate analysis
monogenic diabetes 0.246 established (curated) no MR -> candidate analysis
type 2 diabetes mellitus 0.195 established (curated) no MR -> candidate analysis

Of the 5 rows above, 5 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Bile salt-activated lipase)
gnomAD constraint pLI=2e-09, LOEUF=0.893 — LoF-tolerant
GWAS Catalog 169 unique SNPs / 384 rows
ClinVar 486 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance